Medway Hospitals, headquartered in Chennai, has disclosed the successful acquisition of $5 million in its first-ever institutional equity funding cycle. The investment round was led by Kyra Ventures, along with participation from family offices, as disclosed by the organization. With a presence in Tamil Nadu and Seemandhra, the hospital chain operates eight multispeciality hospitals. Medway Hospitals' areas of expertise encompass critical care, orthopaedics, neurology, nephrology, neurosurgery, organ transplantation, pulmonology, and urology, collectively providing a capacity of nearly 500 beds.

The hospital chain notably established a groundbreaking heart institute in Chennai back in 2021, receiving accreditation from the Joint Commission International and the National Accreditation Board for Hospitals & Healthcare Providers. The Medway Heart Institute has reached significant milestones, performing over 1000 heart surgeries and conducting 3000 cath-lab procedures. Additionally, in 2021, Medway launched an organ transplant program, successfully completing more than 150 renal transplants.

Chairman of Medway Group of Hospitals, T Palaniappan, stressed the institution's commitment to delivering high-quality healthcare services in Tier-II cities and establishing centers of excellence in key urban areas. He expressed that this investment would expedite their expansion plans, aiming to achieve a 1000-bed capacity by 2026. Palaniappan highlighted their hospitals' expertise in managing diverse and intricate medical conditions. Recently, the institution inaugurated the Institute for Pulmonology & Pulmonary Rehabilitation in Chennai to address the escalating respiratory issues among both children and the elderly. Palaniappan reiterated the hospital's efforts to combat the rise in respiratory illnesses, mentioning the launch of this institute to cater to these specific healthcare needs.